UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2682-2695

2005

Volltextzugriff (PDF)

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2008-02, Vol.47 (2), p.428-434

2008

Volltextzugriff (PDF)

Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen

Journal of medical virology, 1991-09, Vol.35 (1), p.55-59

1991

Volltextzugriff (PDF)

Recombinant adenovirus-mediated expression of 1.2-copy hepatitis B virus DNA in three hepatocytes

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2009-04, Vol.29 (4), p.738

2009

Volltextzugriff (PDF)

Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007-09, Vol.27 (9), p.1374

2007

Volltextzugriff (PDF)

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial

Hepatobiliary & pancreatic diseases international, 2005-05, Vol.4 (2), p.213-219

2005

Volltextzugriff (PDF)

Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up

Zhong hua yi xue za zhi, 2007-07, Vol.87 (26), p.1840-1843

2007

Volltextzugriff (PDF)

Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007-08, Vol.27 (8), p.1264

2007

Volltextzugriff (PDF)

Preliminary identification and analysis of point mutations correlated with response to interferon-alpha in hepatitis B virus post-transcriptional regulatory elements

Chinese medical journal, 2005-01, Vol.118 (1), p.56-61

2005

Volltextzugriff (PDF)

Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha

Zhonghua gan zang bing za zhi, 2007-06, Vol.15 (6), p.422

2007

Volltextzugriff (PDF)

The responses of HBcAg specific CTL to HBV/C variants

Zhonghua gan zang bing za zhi, 2006-08, Vol.14 (8), p.624

2006

Volltextzugriff (PDF)

Stable expression of HBV C gene mutants in immortalized human B-cell lines

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2006-06, Vol.26 (6), p.725

2006

Volltextzugriff (PDF)

Impact of virus genotype on interferon treatment of patients with chronic hepatitis C: a multicenter controlled study

Hepatobiliary & pancreatic diseases international, 2004-08, Vol.3 (3), p.369-374

2004

Volltextzugriff (PDF)

Establishment of immortalized B lymphoblast cell line from patients with chronic hepatitis B

Xi bao yu fen zi mian yi xue za zhi, 2006-05, Vol.22 (3), p.330

2006

Volltextzugriff (PDF)

Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China

Journal of medical virology, 1993-03, Vol.39 (3), p.219-223

1993

Volltextzugriff (PDF)

The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients

Zhonghua gan zang bing za zhi, 2006-08, Vol.14 (8), p.565

2006

Volltextzugriff (PDF)

Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients

Zhonghua gan zang bing za zhi, 2005-07, Vol.13 (7), p.488

2005

Volltextzugriff (PDF)

A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B

Chung-hua nei kʿo tsa chih, 2005-09, Vol.44 (9), p.648

2005

Volltextzugriff (PDF)

Retreatment with interferon of relapsed chronic hepatitis C patients

Zhonghua gan zang bing za zhi, 2006-01, Vol.14 (1), p.3

2006

Volltextzugriff (PDF)

Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha

Zhonghua gan zang bing za zhi, 2004-04, Vol.12 (4), p.205

2004

Volltextzugriff (PDF)

Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application

Zhonghua shi yan he lin chuang bing du xue za ji, 2003-03, Vol.17 (1), p.18

2003

Volltextzugriff (PDF)

Establishment of stable expression cell lines for HBsAg variants and analysis of antigenicity

Zhonghua shi yan he lin chuang bing du xue za ji, 2004-03, Vol.18 (1), p.47

2004

Volltextzugriff (PDF)

The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C

Zhonghua gan zang bing za zhi, 2004-02, Vol.12 (2), p.72

2004

Volltextzugriff (PDF)

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or without Hepatitis

Immunological investigations, 1992-01, Vol.21 (3), p.275-281

1992

Volltextzugriff (PDF)

Inhibition of momordica anti-HIV protein of MAP30 on HBeAg expression by laser scanning confocal microscopy

Xi bao yu fen zi mian yi xue za zhi, 2003-03, Vol.19 (2), p.183

2003

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(91)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(38)
Male
(21)
Female
(18)
Hepatitis B Virus - Genetics
(18)
Adult
(17)
Science & Technology
(15)
Middle Aged
(13)
Life Sciences & Biomedicine
(12)
Adolescent
(11)
Recombinant Proteins
(11)
Hepatitis B, Chronic - Drug Therapy
(10)
Hepatitis B, Chronic - Virology
(10)
Interferon-Alpha - Therapeutic Use
(10)
Dna, Viral - Blood
(9)
Antiviral Agents - Therapeutic Use
(8)
Biological And Medical Sciences
(8)
Infectious Diseases
(8)
Medical Sciences
(8)
Human Viral Diseases
(7)
Polymerase Chain Reaction
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa‐2a for HBeAg‐positive chronic hepatitis B

Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen

Recombinant adenovirus-mediated expression of 1.2-copy hepatitis B virus DNA in three hepatocytes

Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial

Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up

Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study

Preliminary identification and analysis of point mutations correlated with response to interferon-alpha in hepatitis B virus post-transcriptional regulatory elements

Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha

The responses of HBcAg specific CTL to HBV/C variants

Stable expression of HBV C gene mutants in immortalized human B-cell lines

Impact of virus genotype on interferon treatment of patients with chronic hepatitis C: a multicenter controlled study

Establishment of immortalized B lymphoblast cell line from patients with chronic hepatitis B

Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China

The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients

Influences of the genotypes of HBV and HBeAg regarding their response to PEG-IFN in chronic hepatitis B patients

A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B

Retreatment with interferon of relapsed chronic hepatitis C patients

Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha

Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application

Establishment of stable expression cell lines for HBsAg variants and analysis of antigenicity

The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or without Hepatitis

Inhibition of momordica anti-HIV protein of MAP30 on HBeAg expression by laser scanning confocal microscopy

Suchergebnisse filtern